Double Hematological and Cardiologic Benefits of Autologous Stem Cell Transplantation in a Case of stage III B IgG Myeloma multiplex and Dilatative Cardiomyopathy – a Case Report

.blurhash-client-img { display: none !important; }

Open Access

|Dec 2015

References

1. Hoffmann R., Benz E.J.Jr. & Silberstein L.E. (2013). Hematology: basic principles and practice. (pp 1328-1334). Elsevier Saunders. Philadelphia, PA, USA.
Search in Google Scholar
2. The EBMT (2008). ESH Handbook Haematopoietic Stem Cell Transplantation (pp 112-128), from http://ebmtonline.forumservice.net/
Search in Google Scholar
3. Zver S1., Zadnik V., Cernelc P. & Kozelj M. (2008). Cardiac toxicity of high-dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation. Int J Hematol. 88(2),227-36. doi: 10.1007/s12185-008-0112-510.1007/s12185-008-0112-518548196
Search in Google Scholar
4. Garbenn J.C. & Lee R.T. (2013). Cardiac Stem Cell Therapy and The Promise of Heart regeneration. Cell Stem Cell. 12(6),689-98. doi: 10.1016/j.stem.2013.05.008.10.1016/j.stem.2013.05.008375630923746978
Search in Google Scholar

DOI: https://doi.org/10.1515/arsm-2015-0050 | Journal eISSN: 1841-4036 | Journal ISSN: 1223-9666

Language: English

Page range: 223 - 226

Published on: Dec 30, 2015

Published by: Ovidius University of Constanta

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Related subjects:

© 2015 Benedek Lazar Erzsebet, I. Benedek, I. Benedek, Kopeczi Judit Beata, Jakab Szende, Tatar Cristina Maria, I. Tilea, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.